{"title":"Study finds gabapentinoid treatment does not elevate risk of self-harm","authors":"","doi":"10.1002/pu.31344","DOIUrl":null,"url":null,"abstract":"<p>A population-based case series study has found that patients taking gabapentin or pregabalin did not experience an elevated risk of self-harm during treatment. Risk of self-harm was elevated during pre- and post-treatment periods, the investigators found. Study results were published online April 30, 2025 in <i>The BMJ</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 9","pages":"1-5"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31344","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A population-based case series study has found that patients taking gabapentin or pregabalin did not experience an elevated risk of self-harm during treatment. Risk of self-harm was elevated during pre- and post-treatment periods, the investigators found. Study results were published online April 30, 2025 in The BMJ.